Commercialization: Page 103
-
PharmaVoice Team/PharmaVoice
Strategies for Building Lasting Relationships with Supporters
Partnerships AmerisourceBergen Specialty Group Jan Heybroek President, Imedex Inc., an AmerisourceBergen Specialty Group company Strategies for Building Lasting Relationships with Supporters For supporters to truly have a strong bond with any CME provider there must be three main compo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Measuring the Future of CME
August 2006 VIEW on Medical Education Metrics Measuring the Future of CME Steven Mankofsky, Director Jane Perrotta, Clinical Editor CME providers need to partner with all stakeholders — physicians, their professional societies, medical specialties, payers, industry — to...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Increasing Educational Reach and Impact Through Integrated Learning Communities
Increasing Educational Reach and Impact Through Integrated Learning Communities Program Development Innovia Education Institute Sarah E. Mooney, Director, Operations and Business Development Successful, integrated educational programming is designed around the premise that the...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Helping Providers Communicate Efficiently and Effectively: Reality-Based Research as a Vehicle for Innovative Medical Education
Communications CommonHealth Chris Tama, President, ProCom Meaghan Nelson, VP, Account Group Director, MBS/Vox Stacey Singer, President, HLS, and Managing Partner, CommonHealth Helping Providers Communicate Efficiently and Effectively: Reality-Based Research as a Vehicle for Innovative M...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Managing Editor The Forum Medical Education Graduates to the Next Level: Physicians rely on continuing medical education, but more than ever they are insisting on high-value content when they invest their time in a program. Company Listing by Topic of Interest Communications Commo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Managing Editor
Medical education is as important as ever for pharmaceutical, biotechnology, and medical-device companies. More important, however, is assessing the value that these programs bring to a physician in terms of behavior change and improving patient care. A Cutting Edge Information report, which stu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Brand Builders
The Brand Builders From advertising to marketing to communications to market research, these brand builders are lifting their art to new heights. Guy Mastrion Truly creative work requires passion, hard work, and a willingness to push boundaries. Guy Mastrion, executive VP and chief global creat...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Commanders and Chiefs
Steering a company in the right direction is no easy task in today’s highly regulated and competitive environment. These individuals wear the mantle of responsibility well and are the guiding forces of ethics, good corporate citizenship, and strategic vision for their companies. Mark Booth Constr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Change Agents
The Change Agents Not content with the status quo, these individuals have decided to shift the paradigm in their fields and are impacting business processes, technologies, and strategies across the life-sciences industry. Mark Bard Keeping the Focus on Results Education B.S. in health administrat...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
GE Healthcare Launches Laboratory Assets System GE Healthcare has introduced Scientific Asset Services, a laboratory asset services offering that can save pharmaceutical and biotechnology companies up to 20% of their total service costs and optimize service operations. Scientific Asset Services p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Making the Web Patient Friendly
As patients and consumers continue to turn to the Internet for health-related information, pharmaceutical marketers are refining their search engine optimization (SEO) strategies to make sure information-hungry consumers are being correctly directed to the right sites. Getting, and Staying, on To...
By Elisabeth Pena Villarroel • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies U.S. Subsidiaries Form Daiichi Sankyo New U.S.-based company expected to fuel growth. Sankyo Pharma Inc., Daiichi Pharmaceutical Corp., and Daiichi Medical Research have integrated their U.S. businesses, creating a new pharmaceutical compan...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Celebrating Compliance
Celebrating compliance successes 5th Annual Patient Compliance, Adherence, and Persistency Conference AstraZeneca’s Commitment to Compliance Astrazeneca is focused on getting the best from every medicine it makes by exploring all the ways it can be used or improved. This commitment to innovation,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overemphasis on Salesforce May Shortchange Promotion
Larry Iaquinto of Interlink discusses why a well-balanced marketing program that includes advertising, public relations, and nonpersonal sales promotion is critical for getting the sales message to customers. Overemphasis on salesforce may shortchange promotion Larry Iaquinto, President and Chief...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DIA Annual Meeting Showcase
DIA Annual Meeting Showcase A review of new products, tools, and services being launched by exhibitors at the 42nd Annual Meeting in Philadelphia, June 18-22. TrialCentralNet 4.0 gives our clients the flexibility to navigate the clinical-study process, communicate real-time study status to collea...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Rising Tide for Clinical Services
A Rising Tide for Clinical Services By Daniel Limbach June 2006 VIEW on Clinical Services Contract drug-development expenditures were $19 billion in 2005 and are expected to increase at an annual rate of 17%, eventually exceeding $42 billio...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Meet the R&D Leaders
By Denise Myshko Executives charged with R&D responsibilities within biotech and pharmaceutical organizations, both large and small, face myriad opportunities and challenges. Drug development is a costly and risky business. The pharmaceutical industry is challenged by many factors related to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Linda DaSilva Kristina Duke Terri Fortenberry Sean Spears David Vaught Cathy Zhang Eisai Hires and Promotes Eisai, Teaneck, N.J., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd., has made several staff appointments. Linda DaSilva has been promoted to senior director, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Meet the R&D leaders Executives charged with R&D responsibilities within biotech and pharmaceutical organizations — large and small — face myriad opportunities and challenges. FEATURES Making the Web patient friendly With a shift in marketing’s focus to direct-to-patient and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Politics and Healthcare Politics and healthcare are inextricably intertwined. What happens on the Hill inevitably impacts the medicine cabinet. But not all politics are good politics. We asked our readers to identify the politicians and lobbyists who understand the medical/pharmaceutical industry...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Throughout the year, PharmaVOICE strives to keep current with the trends and topics that impact our readers’ businesses and roles. We regularly issue e-mail questions soliciting responses for our monthly What’s Your Opinion question and e-surveys that complement various feature articles and Forum...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Office Visits — The Doctor Is In Docs Want More from Rep Calls Pfizer, Novartis, and GlaxoSmithKline have been identified as three companies whose sales reps are doing the best job of meeting the needs of physicians, but a TNS Healthcare study finds that there is room for improvement across the b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Optimizing Sales Performance by Building Brand Commitment
Optimizing Sales Performance by Building Brand Commitment Jeffrey Zornitsky, Senior VP, Sales Performance Optimization Developing high-performing reps is an industry priority. Yet in spite of an annual investment of $24 billion, companies are missing the mark on creating programs that impro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Positioning Sales Training as a Strategic Role in Pharmaceutical Organizations
Positioning Sales Training as a Strategic Role in Pharmaceutical Organizations George Schmidt, Senior Practice Executive, Sales Practice Those salesforces that best understand the changing marketplace and deliver valuable information to physicians will differentia...
By PharmaVoice Team • Jan. 2, 2008
Previous
